Stay Up
to Date
Stay Up
to Date
Breaking News,
Updates, & More
Breaking News,
Updates, & More
Click Here to
Subscribe
Click Here to
Subscribe

TON - April 2013, Vol 6, No 3

TON - April 2013, Vol 6, No 3 published on April 17, 2013
About 3% to 5% of the general population is believed to have a mutation in the gene that encodes a major 5-fluorouracil (5-FU) metabolizing enzyme.
Nurse Navigators and the Continuum of Care
A pproximately 2350 urologists, oncologists, surgeons, radiation oncologists, and other oncology healthcare professionals gathered in Orlando, Florida, to attend the 2013 Genitourinary Cancers Symposium.
TON - April 2013, Vol 6, No 3 published on April 16, 2013 in Supportive Care
Hand-foot skin reaction (HFSR), also known as hand-foot syndrome or palmar-plantar erythrodysesthesia (PPE), is an adverse effect of several chemotherapeutic agents.
TON - April 2013, Vol 6, No 3 published on April 16, 2013 in From the Editors
This issue of The Oncology Nurse-APN/PA (TON) is packed with news about what is happening in the world of oncology research and brings you information that helps you in your day-to-day practice. We highlight news from the 2013 Genitourinary Cancers Symposium and the Hematology/Oncology Pharmacy Association (HOPA) 9th Annual Conference.
TON - April 2013, Vol 6, No 3 published on April 16, 2013 in Noteworthy Numbers
Testicular cancer, or testis cancer, is most often found in young men. With the use of surgery, radiation therapy, and/or chemotherapy, this type of cancer is highly treatable, and it is often curable.
TON - April 2013, Vol 6, No 3 published on April 16, 2013 in Gynecologic Cancers
According to a retrospective review of more than 13,000 cases, most women with ovarian cancer received substandard care that significantly reduced their survival odds.
Page 2 of 2
Results 11 - 17 of 17